SYNOPSIS A method is described for the estimation of adrenaline and noradrenaline in a 5 to 10 ml plasma sample.
The trihydroxyindole (THI) procedure for the fluorimetric determination of catecholamines involves the oxidation of the catecholamines to adrenochrome and noradrenochrome at a slightly acid pH; the addition of a strong alkali causes rearrangement to the fluorescent lutines (3,5,6-trihydroxyindoles) . The alkaline reagent used is concentrated sodium hydroxide containing a reducing agent, generally ascorbic acid, which stabilizes the fluorescence of the lutines. Merrills (1962) has recently shown that if thioglycollic acid is used as the reducing agent only the fluorescent product of noradrenaline is stabilized. This observation forms the basis of an automated method for the differential determination of adrenaline and noradrenaline described by Merrills (1963) . Robinson and Watts (1965) have modified this method and used it to determine adrenaline and noradrenaline in urine, rat hearts, adrenals, and adrenal vein blood. Fiorica (1965) increased the sensitivity of the automated method in order to measure the total catecholamine concentration in human plasma, but did not attempt to differentiate the two catecholamines.
The present paper describes a method for the determination of adrenaline and noradrenaline in human plasma, in which a simple batch technique for the isolation of the catecholamines on alumina has been introduced to replace the more time consuming process involving columns. The automated method of determination is based on the technique described by Fiorica (1965) with differentiation of the catecholamines according to Merrills (1963) .
Received for publication 25 March 1968. 759 REAGENTS All chemicals used were analytical grade. Water used throughout the method was deionized.
1 ALUMINA (B.D.H. REAGENT GRADE) Alumina, 250 g, in a 500 ml stoppered container, was washed with 5 x 200 ml 0-3N acetic acid, and 5 x 200 ml deionized water. Each wash was shaken gently for five minutes using a mechanical shaker and the alumina was allowed to settle for approximately one minute before aspirating.
All fine alumina particles should be removed during this procedure.
The final water wash was neutralized with NaHCO3/-Na2CO3 buffer (3 g each/100 ml). Water washes of 200 ml were continued until no change in pH of the wash was detected before and after shaking. The alumina was dried in an oven at 105°C and the recovery of catecholamines from each new batch of alumina was checked before use.
2 SODIUM ACETATE BUFFER, 0-2M The buffer was adjusted to pH 8-4 with 0-5N sodium carbonate. 9 ASCORBIC ACID, 0. 15 % This solution was prepared immediately before use.
10 THIOGLYCOLLIC ACID, 1 % This solution was prepared and adjusted to pH 3 27 with 4N NaOH immediately before use.
11 HYDROCHLORIC ACID, 0O-1N 12 SODIUM METABISULPHITE, 10 MG/ML Of this reagent 0 5 ml was added to heparinized tubes and dried. STANDARDS STOCK STANDARDS These were prepared monthly and stored at -40C. ADRENALINE, 1 MG/ML L-Adrenaline bitartrate monohydrate, 18-2 mg, as L-epinephrine bitartrate (Sigma), in 10 ml 0O-1N HCI.
NORADRENALINE, 1 MG/ML L-noradrenaline bitartrate monohydrate, 19 9 mg, as L-arterenol (Sigma), in 10 ml 0-01N HCl.
WORKING STANDARDS
These were prepared immediately before use. (1) 10 ug/ml, 1 ml stock in 100 ml water; (2) 0-1 ug/ml, 1 ml (1) in 100 ml water; (3) 5 ,ug/l. 5 ml (2) in 100 ml water. Five ml sodium metabisulphite 10 mg/ml was used in making up each standard. Then 0, 1-0, 2-0, 3-0, 4 0, 5 0, 6-0 ml (0 to 3 lzg/l.) working standards were pipetted into buckets containing 1 ml 4N HCl04.
APPARATUS
All glassware was very carefully washed to prevent contamination with fluorescent compounds, particularly those present in tap water and detergents. No detergent was used, and after thorough washing with tap water, all glassware was rinsed twice with deionized water.
DEBUBBLER
Adsorption tubes were washed in batches with 2 x 20 ml deionized water before use.
The following are required: (1) 12 ml tubes containing 1 ml perchloric acid stored at 4°C; (2) 30 ml plastic buckets with lids; (3) 30 ml glass stoppered centrifuge tubes, internal diameter 25 mm; (4) mechanical shaker and shaking racks; (5) pH meter and glass electrode; (6) automatic burette for 2 ml delivery of 0 3N acetic acid.
The autoanalyser was used with a Locarte fluorimeter, using a hydrogen lamp as the ultraviolet source. The primary filter was a Locarte LF2 (360 to 380 m,), and the secondary filter, an LF7 which passes all wavelengths longer than 510 m,-.
The flow system is shown in Fig. 1 and was used in conjunction with a type II sampler to ensure a constant air: fluid ratio within the system. PROCEDURE SAMPLE COLLECTION AND STORAGE Blood was collected in two 10 ml heparinized tubes each containing 5 mg sodium metabisulphite as antioxidant, and chilled in ice until centrifuged. The plasma was separated and a 5 to 10 ml sample pipetted into tubes containing 1 ml 4N perchloric acid. After thorough mixing the tubes were centrifuged at 30,000 x g for 15 minutes, and the supernatant was transferred to 30 ml buckets with 1 ml of acetate buffer.
The deproteinized acid extracts were stored at -4°C until required for analysis which was generally carried out within a week although the solutions were stable for up to one month. ADSORPTION Batches of 12 tubes could be conveniently handled at one time and two or three batches could be prepared for analysis in one day. EDTA, 1 ml, and 5 ml acetate buffer were added to each bucket, the standards, tests, and blank being treated in the same way.
The pH of the solution was adjusted to 8-4 ± 0-1 by dropwise addition of 5N sodium carbonate, with continuous mixing until a constant pH was maintained. The Semi-automated method for the differential determination ofplasma catecholamines contents of the bucket were transferred with 1 ml of acetate buffer to 30 ml tubes containing 500 mg alumina. CALCULATION Standard curves were constructed by plotting the peak heights of the standards, in both stabilizing agents, against the initial concentration of catecholamines (0 to 3 ,Ag/l.), and the total catecholamine and noradrenaline concentrations of the 10 ml plasma sample were read from the ascorbic and thioglycollic acid graphs (Fig. 2) . The concentration of adrenaline was obtained from the difference between the two values.
RESULTS
STANDARD CURVE Over a range of 0 to 25 ,tg/l., which is equivalent to 0 to 5 ,ug/l., initial concentration due to the five-fold concentration attained by adsorption on alumina, the fluorescence intensity is related in a linear manner to the concentration of both catecholamines in ascorbic acid and to the concentration of noradrenaline in thioglycollic acid. Figure 2 shows the standard curves obtained over the range 0 to 3 ,tg/l. initial concentration after adsorption and elution from alumina.
REPRODUCIBILITY To determine the precision of the method, duplicate samples were analysed for total catecholamine and noradrenaline content over various concentration ranges. Results are summarized in Table I. RECOVERY Samples, 10 ml of each standard (1 to 5 ug/l.), were carried through the entire A 500 mg portion of the tu 100 ml 4N perchloric acid metabisulphite. The extract wi for 15 minutes and a 1 ml ; diluted to 500 ml in 4N peri dilutions were prepared frorr 1:50 and 1:100 in 4N perchlc of each dilution were taken The tumour was found to co aline and 4-4 ,ug/mg adrenal von Euler (1956) for the resting levels of adrenarenous peripheral blood rmal male subjects aged ch rested for at least 10 dean resting concentra-*ollows: total catechola-81 ,ug/l.), noradrenaline 1.), adrenaline 0-02 ,ug/l.
were determined in tumours ranged from 0-63 to 8-40 ug/mg noradrenaline, 005 to 2-30 tg/mg adrenaline, 0 70 to 9 7 ,ug/mg total catecholamines.
A bioassay of the tumour was carried out independently (Glover and Wallace) using the isolated central artery of the rabbit ear (de la Lande and Harvey, 1965) . The result, 11-7 ,ug/mg of total catecholamine, was in good agreement with the automated trihydroxy indole method (Glover, McCullough, and Wallace, 1967) . other methods, which depend on the suppression of e determined in a patient noradrenaline fluorescence, since the relative fluores-)f the bladder, which was cence of the amines in the two stabilizing reagents ppeared to be of a non-is very different (Robinson and Watts, 1965 ).
itient's clinical symptoms
In the present method several modifications of ifirmed by determination Merrills' original (1962) method are present. The s in plasma drawn from 0.3% ascorbic acid has been replaced by a 0-15% ;hown in Table II were solution as recommended by Robinson and Watts ,cept in the region of the (1965) since this reagent gives a reduced reagent as subsequently removed baseline without decreasing the sensitivity or ttion it was considered to stability of the fluorescent products. Letters to the Editor THYROID FUNCTION TESTS I was most interested in the paper by Thomson, Boyle, McGirr, Macdonald, Nicol, and Brown (1968) Thyroid function tests fall into two groups, first those which aim to determine 'thyroid status', and secondly those directed at specific thyroid disorders independent of thyroid status. The commonest example of the second group is the diagnosis of Hashimoto's disease by demonstration of high titres of specific antibodies to thyroid components in the peripheral blood. A patient with Hashimoto's disease may be euthyroid, hypothyroid or, rarely, thyrotoxic, but the antibody findings are quite independent of this aspect. It is useful, when considering and comparing tests of thyroid function, to separate the two groups of investigations to avoid confusion.
The authors state in their synopsis that 'an uptake test and estimation of the serum protein-bound radioactive iodine (PB1311), supplemented as required by the protein-bound iodine (PBI), remain the best routine tests of thyroid function'. This conclusion is not based on a comparison with the variety ofnewer tests now available, of which they used only the triiodothyronine resin uptake in a few cases. Although their statement might have been valid between 1963 and 1965, when the work was done, it does less than justice to the many authors who have published studies since then.
Recent work on the determination of thyroid status has largely been concerned with the direct measurement of levels of thyroid hormone in blood. Ekins (1960) and Murphy (1965) developed specific thyroxine assay techniques based on the saturation analysis principle and Nauman, Nauman, and Werner (1967) described a method for the determination of serum triiodothyronine also based on this technique. These methods eliminate inaccuracies inherent in PBI measurements by being specific for the hormones themselves. Following the extensive development by Robbins and Rall (1957) of the concept of protein-binding of thyroid hormones in blood, it has been recognized that thyroid function is most closely related to the concentration of unbound hormone. This level is dependent on the concentrations of thyroxine-binding globulin (TBG) and thyroxinebinding prealbumin (TBPA), as well as on the level of total thyroid hormone. Free thyroxine can be measured directly by equilibrium dialysis or ultrafiltration, and indirectly by methods derived from that of Hamolsky, Stein, and Freedberg (1957) which reflect the concentration of thyroxine-binding proteins. These have been well Journal of Clinical Pathology, 1968, 21, 511. 
